Detection of Minimal Residual Disease in B Cell Acute Lymphoblastic Leukemia Using an Eight‐Color Tube with Dried Antibody Reagents
Author:
Affiliation:
1. Assistance Publique Hôpitaux de MarseilleLaboratoire d'Hématologie, Hôpital de la Timone Marseille France
2. CNRS, INSERM, CIMLAix Marseille University Marseille France
Publisher
Wiley
Subject
Cell Biology,Histology,Pathology and Forensic Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/cyto.b.21766
Reference17 articles.
1. Clinical Significance of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia
2. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
3. Minimal Residual Disease in Acute Lymphoblastic Leukemia
4. Flow cytometry and IG/TCR quantitative PCR for minimal residual disease quantitation in acute lymphoblastic leukemia: a French multicenter prospective study on behalf of the FRALLE, EORTC and GRAALL
5. Improved flow cytometric detection of minimal residual disease in childhood acute lymphoblastic leukemia
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Blinatumomab as postremission therapy replaces consolidation and substantial parts of maintenance chemotherapy and results in stable MRD negativity in children with newly diagnosed B-lineage ALL;Journal for ImmunoTherapy of Cancer;2024-06
2. The Evolving Landscape of Flowcytometric Minimal Residual Disease Monitoring in B-Cell Precursor Acute Lymphoblastic Leukemia;International Journal of Molecular Sciences;2024-04-30
3. The Use of Flow Cytometry for MRD Detection of B- and T-ALL in Pediatric Patients;Reference Module in Biomedical Sciences;2024
4. Minimal residual disease monitoring in B-lineage acute lymphoblastic leukemia using flow cytometry. Guidelines of the Russian-Belarusian multicenter group for pediatric acute leukemia studies;Pediatric Hematology/Oncology and Immunopathology;2023-10-03
5. Guidelines for the flow cytometric minimal residual disease monitoring in B-lineage acute lymphoblastic leukemia after CD19-directed immunotherapy;Pediatric Hematology/Oncology and Immunopathology;2023-05-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3